Moreover, studies have shown that depletion of OTUD7B markedly reduces the proliferation and migration capabilities of ERα-positive breast cancer cells, whereas overexpression of ERα can counteract the inhibitory effects induced by OTUD7B depletion [27]. The gene discussed is ESR1; the disease is breast carcinoma.